Меню
Идёт набор NCT06080464

Clinician Satisfaction With the VERABAND™

Без фазы С лечением Chronic Low-back Pain

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: VERABAND information.
Кому может быть актуально
Состояния в реестре: Chronic Low-back Pain. Базовые параметры: 18 лет — 85 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

A Study of Clinician Satisfaction and Likelihood of Clinical Adoption of the VERABAND™

Обзор

The VERABAND™ is a newly-developed, disposable, wearable activity monitor. The researchers will assess clinician satisfaction with the usability and likelihood of clinical adoption of the newly-developed, disposable, wearable activity monitor, across multiple clinical sites in the chronic low back pain (cLBP) population.

Подробное описание

A total of 340 cLBP patients (estimating n=300 completers) will be recruited and evaluated under an approved institutional review board (IRB) protocol by a total of 20 clinician participants distributed across multiple tertiary pain clinics. Consented patient participants will be given a VERABAND™ activity monitor during an initial clinic visit (baseline) and will then be tracked longitudinally after beginning a new pain treatment regime as part of their normal ongoing care. VERABAND™ activity data reports (including a summary broken down by week) will subsequently be provided to treating clinicians prior to each patient's follow-up clinic visit. The primary outcome will be clinician satisfaction with usability of the VERABAND™ system to support clinical cLBP management, regardless of the specific treatment(s) implemented or their analgesic effectiveness. Each clinician will complete a usability satisfaction survey at the end of each patient's episode of care, which allows for exploratory analyses to identify whether the VERABAND™ system is perceived to be more useful for specific patient phenotypes (e.g., those with higher levels of pain and/or disability or specific psychological characteristics).

Вмешательства

  • Другое VERABAND information
    The device, VERABAND™, activity data reports (including a summary broken down by week) will be provided to treating clinicians prior to each patient's follow-up clinic visit.

Первичные конечные точки

  • Measure clinician satisfaction of the usability of the VERABAND™ using the System Usability Scale (SUS) [Срок оценки: approximately 7 weeks]
  • Measure the likelihood of clinical adoption of the VERABAND™ using Item 1 of the System Usability Scale (SUS) [Срок оценки: approximately 7 weeks]

Критерии участия

Any treating clinician at a recruiting tertiary pain clinic will be eligible to participate.

Patient participants must meet the following criteria:

Критерии включения

  • Ambulatory
  • Diagnosis of chronic low back pain (cLBP) according to the criteria of National Institute of Health (NIH) Task Force on Research Standards for cLBP
  • Answering 'Yes' to the question: Does your low back pain interfere with your mobility?
  • Starting any new non-surgical treatment or combination of treatments for cLBP as part of their normal ongoing care, including medications; physical therapy/exercise; integrated therapies (e.g., massage, acupuncture, yoga); cognitive- behavioral therapy; and/or interventional procedures (e.g., epidural steroid or facet joint injections)
  • Willingness to wear a VERABAND™ continuously until their next clinic visit and return used devices in the mail.

Критерии исключения

  • Clinical findings suggesting the presence of ongoing systemic disease, including fever, weight loss, initiation of pain following major trauma, immunosuppression, intravenous drug use, recent bacterial infection, severe or persistent sensory or motor involvement of bowel, bladder, or lower extremity; or any condition that would greatly limit physical activity not due to pain.
  • Inability to speak and write English.
  • Visual or hearing difficulties that would preclude participation.
  • Severe psychiatric disorders that in the opinion of the investigative team would interfere with participation in the study. This includes any active suicidal ideations or history of suicide attempts. Exclusions will be based on self-reported medical history or chart review and in accordance with Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria.
  • Individuals receiving disability or compensation or involved in litigation.
  • Scheduled surgery before follow-up.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Не применимо
Модель
Одна группа
Маскирование
Открытое
Основная цель
Организация здравоохранения

Центры проведения

США · 3 центра
  • Altman Clinical and Translational Research Institute — La Jolla
  • University of Kansas Medical Center — Kansas City
  • University of Michigan — Ann Arbor

Идентификаторы

NCT: NCT06080464 · HUM00235976 · 1U44NS122002

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗